Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Europa Stream

 

HBI 2026: How pharma services can maintain scalability and differentiation

The pharma services sector is recovering, but unevenly. Biotech funding has returned to healthy levels, and trial starts are rebounding to previous peak levels. However, geopolitical challenges and AI disruption fears persist.  At HBI 2026, a panel discussed the challenges and opportunities facing the pharma services sector.
April 28, 2026

HBI 2026: Relieving the pressure; Investment, innovation and value creation in elderly and social care

Europe’s elderly care sector is in recovery mode after a difficult few years. Investment into the sector surged in 2025, particularly on the real estate investment side in the UK market. Looking ahead, panellists speaking at the ‘Relieving the Pressure: Investment, innovation and value creation in elderly and social care’ session at HBI’s 2026 conference seemed to paint a bright-looking future, given the increase in demand as baby boomers age combined with promising innovations in technology and care delivery models.
April 23, 2026

Medtronic invests in China’s Pulnovo

Pulnovo Medical, a China-based medtech company developing treatments for pulmonary hypertension and heart failure, has raised $100 million in an oversubscribed round led by Medtronic, the world’s largest medtech company.
April 23, 2026

TA Associates in final talks to buy AMS

US private equity firm TA Associates is in advanced talks to acquire Advanced Medical Solutions (AMS), the UK-listed company that develops surgical products including adhesives, sutures, haemostats and internal sealants under brands such as LiquiBand and RESORBA. Under UK takeover rules, TA Associates typically has until around mid-May 2026 to either announce a firm intention to bid or withdraw.
April 23, 2026

German insurer Barmer will reimburse Austrian femtech Hello Inside

Barmer, Germany’s second largest non-profit statutory health insurer with around 8.7 million members, has partnered with Austrian femtech company Hello Inside to offer its metabolic health programme as a reimbursed prevention service. Mario Aichlseder, Hello Inside’s co-founder, explained to us how this an important step in demonstrating that the company’s offering is a healthcare product, rather than a wellness product.
April 23, 2026

Everstone Capital invests $270 million in Apothecon Group

Singapore-based private equity firm Everstone Capital has invested around $270 million in Apothecon Group, a specialty pharma Contract Development and Manufacturing Organisation (CDMO). The combined group includes India-based Apothecon and US-based Navinta. Together, they work on complex molecules, mainly in iron and peptide-based chemistry.
April 23, 2026

Nord Holding buys stake in VisionmaxX Group

Private equity firm Nord Holding has acquired a majority stake in the VisionmaxX Group, a German healthcare IT service provider. VisionmaxX provides IT services, including IT infrastructure, telematics, IT security, and digital practice solutions for German and Austrian dental practices, orthodontists, and oral and maxillofacial surgeons.
April 20, 2026
Older posts
Newer posts

Our Services

Company

Resources

Log in
Register
Log in
Register

Our Services

Company

Resources

Find Us